Search Results - "Rodríguez‐heredia, José Manuel"

Validity, reproducibility, and responsiveness of a twelve‐joint simplified power doppler ultrasonographic assessment of joint inflammation in rheumatoid arthritis by Naredo, Esperanza, Rodríguez, Manuel, Campos, Cristina, Rodríguez‐heredia, José Manuel, Medina, Julio A., Giner, Emilio, Martínez, Olga, Toyos, Francisco Javier, Ruíz, Teresa, Ros, Inmaculada, Pujol, Manuel, Miquel, Xavier, García, Luz, Aznar, Juan José, Chamizo, Eugenio, Páez, Manuel, Morales, Pilar, Rueda, Amalia, Tuneu, Roser, Corominas, Hector, de Agustín, Juan José, Moragues, Carmen, Mínguez, Dolores, Willisch, Alfredo, González‐cruz, Isabel, Aragón, Angel, Iglesias, Gerardo, Armas, Carlos, Pablo valdazo, Juan, Vargas, Carmen, Calvo‐alén, Jaime, Juan‐mas, Antonio, Salvador, Georgina, Puigdollers, Angels, Galíndez, Eva, Garrido, Noemi, Salaberri, José, Raya, Enrique, Salles, Meritxell, Díaz, César, Cuadra, José luis, Garrido, Jesús

“…Objective To investigate the validity, reproducibility, and responsiveness of a simplified power Doppler ultrasound (PDUS) assessment of joint inflammation…”
Get full text

Disease activity indexes might not capture the same disease aspects in males and females with ankylosing spondylitis: A real-world nationwide analysis by Fernández-Carballido, Cristina, Jovaní, Vega, Catalán, Emma Beltrán, Moreno-Ramos, Manuel José, Sanz Sanz, Jesús, Gallego, Adela, García Vivar, M Luz, Rodríguez-Heredia, José Manuel, Sanabra, Cristina, Sastré, Carlos

“…To evaluate gender differences in disease activity and health status (HS) in patients with radiographic axial spondyloarthritis (r-axSpA)/ankylosing…”
Get full text

Severe COVID-19 in patients with immune-mediated rheumatic diseases: A stratified analysis from the SORCOM multicentre registry by Boteanu, Alina, Leon, Leticia, Pérez Esteban, Silvia, Rabadán Rubio, Elena, Pavía Pascual, Marina, Bonilla, Gema, Bonilla González-Laganá, Carmen, García Fernandez, Antia, Recuero Diaz, Sheila, Ruiz Gutierrez, Lucia, Sanmartín Martínez, José Javier, de la Torre-Rubio, Natalia, Nuño, Laura, Sánchez Pernaute, Olga, Del Bosque, Iván, Lojo Oliveira, Leticia, Rodríguez Heredia, José Manuel, Clemente, Daniel, Abasolo, Lydia, Bachiller-Corral, Javier

“…The aim of this study is to evaluate risk factors for severe coronavirus disease 2019 (COVID-19) in patients with immune-mediated rheumatic diseases,…”
Get full text

Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis by Loza, Estíbaliz, Lajas, Cristina, Andreu, Jose Luis, Balsa, Alejandro, González-Álvaro, Isidoro, Illera, Oscar, Jover, Juan Ángel, Mateo, Isabel, Orte, Javier, Rivera, Javier, Rodríguez Heredia, José Manuel, Romero, Fredeswinda, Martínez-López, Juan Antonio, Ortiz, Ana María, Toledano, Esther, Villaverde, Virginia, Carmona, Loreto, Castañeda, Santos

“…The objective of the study was to develop evidence-based and practical recommendations for the detection and management of comorbidity in patients with…”
Get full text

Biologic Disease-modifying antirheumatic drug attributes in the first lines of treatment of rheumatoid arthritis. 2015 ACORDAR project by Muñoz-Fernández, Santiago, Bustabad Reyes, María Sagrario, Calvo Alén, Jaime, Castaño Sánchez, Manuel, Chamizo Carmona, Eugenio, Corominas, Héctor, Fernández-Llanio Comella, Nagore, Hidalgo Calleja, María Cristina, Pérez Venegas, José Javier, Rodríguez Heredia, José Manuel, Romero Yuste, Susana María, Ruiz-Esquide Torino, Virginia

“…To date, between 17% and 35% of patients with rheumatoid arthritis (RA) do not respond as expected to the initial biological therapy. The objective of this…”
Get full text

Cost per response for abatacept versus adalimumab in patients with seropositive, erosive early rheumatoid arthritis in the US, Germany, Spain, and Canada by Foo, Jason, Morel, Chaienna, Bergman, Martin, Baerwald, Christoph, Rodriguez-Heredia, José Manuel, Marshall, Alexander, Polanco-Sánchez, Carlos, Postema, Roelien

“…Background Effective treatment of rheumatoid arthritis (RA) with biologic DMARDs poses a significant economic burden. The AMPLE (Abatacept versus adaliMumab…”
Get full text

Use of prognostic factors of rheumatoid arthritis in clinical practice and perception of their predictive capacity before and after exposure to evidence by Muñoz-Fernández, Santiago, Otón-Sánchez, Teresa, Carmona, Loreto, Calvo-Alén, Jaime, Escudero, Alejandro, Narváez, Javier, Rodríguez Heredia, Jose Manuel, Romero Yuste, Susana, Vela, Paloma, Luján Valdés, Sara, Royo García, Ana, Baquero, José Luis

“…The aim of the study is to benchmark the use and attributed importance of well-established prognostic factors in rheumatoid arthritis (RA) in daily clinical…”
Get full text

Influence of prognosis factors on the prescription of targeted treatments in rheumatoid arthritis: A Delphi survey by Narváez, Javier, Otón, Teresa, Calvo-Alén, Jaime, Escudero-Contreras, Alejandro, Muñoz-Fernández, Santiago, Rodríguez-Heredia, José Manuel, Romero-Yuste, Susana, Vela-Casasempere, Paloma, Luján, Sara, Baquero, Jose Luis, Carmona, Loreto

“…•It is unclear whether rheumatologist takes into account specific poor prognostic factors when deciding a treatment beyond classic DMARDs in RA.•The effect of…”
Get full text

Evaluation of the impact of nursing clinics in the rheumatology services by Muñoz-Fernández, Santiago, Aguilar, Ma Dolores, Rodríguez, Amparo, Almodóvar, Raquel, Cano-García, Laura, Gracia, Luís Antonio, Román-Ivorra, José A., Rodríguez, J. Ramón, Navío, Teresa, Lázaro, Pablo

“…Nursing clinics in rheumatology (NCRs) are organisational care models that provide care centred within the scope of a nurse’s abilities. To analyse the impact…”
Get full text

Biologic Disease-modifying Antirheumatic Drug Attributes in the First Lines of Treatment of Rheumatoid Arthritis. 2015 ACORDAR Project by Muñoz-Fernández, Santiago, Bustabad Reyes, María Sagrario, Calvo Alén, Jaime, Castaño Sánchez, Manuel, Chamizo Carmona, Eugenio, Corominas, Héctor, Fernández-Llanio Comella, Nagore, Hidalgo Calleja, María Cristina, Pérez Venegas, José Javier, Rodríguez Heredia, José Manuel, Romero Yuste, Susana María, Ruiz-Esquide Torino, Virginia

“…To date, between 17% and 35% of patients with rheumatoid arthritis (RA) do not respond as expected to the initial biological therapy. The objective of this…”
Get full text

Atributos del fármaco antirreumático modificador de la enfermedad biológico en las primeras líneas de tratamiento de la artritis reumatoide. Proyecto ACORDAR 2015 by Muñoz-Fernández, Santiago, Bustabad Reyes, María Sagrario, Calvo Alén, Jaime, Castaño Sánchez, Manuel, Chamizo Carmona, Eugenio, Corominas, Héctor, Fernández-Llanio Comella, Nagore, Hidalgo Calleja, María Cristina, Pérez Venegas, José Javier, Rodríguez Heredia, José Manuel, Romero Yuste, Susana María, Ruiz-Esquide Torino, Virginia

“…Resumen Objetivo Existen pacientes con artritis reumatoide (AR) que no responden de la forma deseada a la terapia biológica. Nuestro objetivo fue reconocer los…”
Get full text

Docencia postgrado: ¿Quién? ¿Dónde? ¿Cuándo? by José Manuel Rodríguez Heredia, Ángel Gallegos Cid, Jesús García-Arroba Muñoz

Get full text

Docencia postgrado: ¿Quién? ¿Dónde? ¿Cuándo? Postgraduate Teaching: Who?, Where?, When? by José Manuel Rodríguez Heredia, Ángel Gallegos Cid, Jesús García-Arroba Muñoz

Get full text

Docencia postgrado: ¿Quién? ¿Dónde? ¿Cuándo? by Rodríguez Heredia, José Manuel, Gallegos Cid, Ángel, García-Arroba Muñoz, Jesús

Get full text

Docencia postgrado: ¿Quién? ¿Dónde? ¿Cuándo? by Rodríguez Heredia, José Manuel, Gallegos Cid, Ángel, García-Arroba Muñoz, Jesús

Get full text